March 12, 2015 - The court granted the defendants' motions to dismiss.
July 28, 2014 - The defendants filed motions to dismiss.

May 28, 2014 - The lead plaintiff filed an amended complaint.

March 26, 2014 - The lead plaintiff and lead counsel were appointed and all cases were consolidated.

March 17, 2014 - Lead plaintiff motions were filed.

January 16, 2014 - An investor in shares of Merge Healthcare Incorporated (NASDAQ: MRGE) filed a lawsuit in the U.S. District Court for the Northern District of Illinois against Merge Healthcare Incorporated over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between August 1, 2012 and January 7, 2014.

According to the complaint the plaintiff alleges on behalf of all persons or entities who purchased or otherwise acquired securities of Merge Healthcare Incorporated (NASDAQ: MRGE) between August 1, 2012 and January 7, 2014, that Merge Healthcare Incorporated and certain of its officers and directors violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. More specifically, the plaintiff claims that the defendants allegedly misrepresented or failed to disclose that both the existence and value of millions of dollars of Merge Healthcare Incorporated’s eClinical customer contracts had been falsified, and as a result Merge Healthcare Incorporated’s reported subscription backlog was overstated during the six quarters ended September 30, 2013, and that Merge Healthcare Incorporated was experiencing a continued reluctance amongst large health systems to move forward with enterprise imaging purchases.

In June 2012 Merge Healthcare Incorporated (NASDAQ: MRGE) shares traded at $2.22 per share. On July 31, 2012 Merge Healthcare Incorporated reported its financial and business results for the second quarter in 2012.

Merge Healthcare Incorporated (NASDAQ: MRGE) shares grew to as high as $3.91 per share in September 2012.

On February 19, 2013, Merge Healthcare Incorporated reported its financial and business results for the fourth quarter of 2012. Merge Healthcare Incorporated reported that its annual Total Revenue rose from 232.43 million in 2011 to $248.90 million in 2012 and that its respective Net Loss increased from $5.52 million to $28.80 million. On May 1, 2013, Merge Healthcare Incorporated announced its “record first quarter sales” along with its other financial and business results for the first quarter of 2013.

Shares of Merge Healthcare Incorporated (NASDAQ: MRGE) grew from $2.22 per share in June 2012 to as high as $4.55 per share in July 2013.

Then on August 9, 2013, Merge Healthcare Inc announced its financial and business results for the second quarter of 2013. Among other things, Merge Healthcare Inc announced that its board of directors has accepted the resignation of Jeffery A. Surges as Chief Executive Officer and Director of Merge Healthcare Incorporated.

Shares of Merge Healthcare Incorporated (NASDAQ: MRGE) declined from $4.51 per share on August 2, 2013, to $2.43 per share on August 9, 2013.

Then on January 8, 2014, Merge Healthcare Incorporated announced that it recently learned through an internal review that a former sales employee in its eClinical business had falsified the existence or amount of certain customer contracts.

Merge Healthcare Incorporated said that while no restatement of any of Merge Healthcare Incorporated’s prior financial statements is necessary or will be made, it, however, is reducing its previously-announced non-GAAP subscription backlog totals for the Merge DNA segment for the quarterly periods ended June 30, 2012 through September 30, 2013.

Shares of Merge Healthcare Incorporated (NASDAQ: MRGE) declined from $2.58 per share on January 3, 2014, to $2.08 per share on January 9, 2014.